WB
The startup develops silica nano-particle technology that utilizes nanocarriers to enhance the delivery of chemotherapeutic agents specifically for pancreatic and colon cancer treatment. This approach aims to improve drug pharmacokinetics and tissue concentration while minimizing systemic toxicity associated with conventional chemotherapy.
Updated 3 months ago
Funding
$3.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops silica nano-particle technology that utilizes nanocarriers to enhance the delivery of chemotherapeutic agents specifically for pancreatic and colon cancer treatment. This approach aims to improve drug pharmacokinetics and tissue concentration while minimizing systemic toxicity associated with conventional chemotherapy.